• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于喷雾干燥无定形固体分散体研发的筛选方法

Screening methodologies for the development of spray-dried amorphous solid dispersions.

作者信息

Duarte Íris, Santos José Luís, Pinto João F, Temtem Márcio

机构信息

iMed - Research Institute for Medicines and Pharmaceutical Sciences, University of Lisbon, Faculty of Pharmacy, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.

出版信息

Pharm Res. 2015 Jan;32(1):222-37. doi: 10.1007/s11095-014-1457-5. Epub 2014 Aug 19.

DOI:10.1007/s11095-014-1457-5
PMID:25135702
Abstract

PURPOSE

To present a new screening methodology intended to be used in the early development of spray-dried amorphous solid dispersions.

METHODS

A model that combines thermodynamic, kinetic and manufacturing considerations was implemented to obtain estimates of the miscibility and phase behavior of different itraconazole-based solid dispersions. Additionally, a small-scale solvent casting protocol was developed to enable a fast assessment on the amorphous stability of the different drug-polymer systems. Then, solid dispersions at predefined drug loads were produced in a lab-scale spray dryer for powder characterization and comparison of the results generated by the model and solvent cast samples.

RESULTS

The results obtained with the model enabled the ranking of the polymers from a miscibility standpoint. Such ranking was consistent with the experimental data obtained by solvent casting and spray drying. Moreover, the range of optimal drug load determined by the model was as well consistent with the experimental results.

CONCLUSIONS

The screening methodology presented in this work showed that a set of amorphous formulation candidates can be assessed in a computer model, enabling not only the determination of the most suitable polymers, but also of the optimal drug load range to be tested in laboratory experiments. The set of formulation candidates can then be further fine-tuned with solvent casting experiments using a small amount of API, which will then provide the decision for the final candidate formulations to be assessed in spray drying experiments.

摘要

目的

介绍一种旨在用于喷雾干燥无定形固体分散体早期开发的新筛选方法。

方法

实施一个结合热力学、动力学和制造因素的模型,以获得不同伊曲康唑基固体分散体的混溶性和相行为估计值。此外,开发了一种小规模溶剂浇铸方案,以便能够快速评估不同药物-聚合物体系的无定形稳定性。然后,在实验室规模的喷雾干燥器中制备预定义药物载量的固体分散体,用于粉末表征,并比较模型和溶剂浇铸样品产生的结果。

结果

从混溶性角度来看,模型获得的结果能够对聚合物进行排序。这种排序与通过溶剂浇铸和喷雾干燥获得的实验数据一致。此外,模型确定的最佳药物载量范围也与实验结果一致。

结论

本研究中提出的筛选方法表明,一组无定形制剂候选物可在计算机模型中进行评估,不仅能够确定最合适的聚合物,还能确定在实验室实验中测试的最佳药物载量范围。然后,可以使用少量活性药物成分通过溶剂浇铸实验对制剂候选物组进行进一步微调,这将为在喷雾干燥实验中评估的最终候选制剂提供决策依据。

相似文献

1
Screening methodologies for the development of spray-dried amorphous solid dispersions.用于喷雾干燥无定形固体分散体研发的筛选方法
Pharm Res. 2015 Jan;32(1):222-37. doi: 10.1007/s11095-014-1457-5. Epub 2014 Aug 19.
2
Development of a small-scale spray-drying approach for amorphous solid dispersions (ASDs) screening in early drug development.开发一种小规模喷雾干燥方法用于早期药物开发中无定形固体分散体(ASD)的筛选。
Pharm Dev Technol. 2019 Jun;24(5):560-574. doi: 10.1080/10837450.2018.1534861. Epub 2018 Nov 6.
3
Comparison of spray drying, electroblowing and electrospinning for preparation of Eudragit E and itraconazole solid dispersions.喷雾干燥、静电纺丝和电喷技术制备 Eudragit E 和伊曲康唑固体分散体的比较。
Int J Pharm. 2015 Oct 15;494(1):23-30. doi: 10.1016/j.ijpharm.2015.07.076. Epub 2015 Aug 1.
4
Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.溶剂对无定形固体分散体的相行为和玻璃化转变的影响。
Eur J Pharm Biopharm. 2021 Jan;158:132-142. doi: 10.1016/j.ejpb.2020.11.002. Epub 2020 Nov 16.
5
Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and eudragit e100.制备方法对无定形固体分散体固态过饱和度的影响:以伊曲康唑和 Eudragit E100 为例。
Pharm Res. 2010 May;27(5):775-85. doi: 10.1007/s11095-010-0069-y. Epub 2010 Mar 2.
6
Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.从过饱和喷雾干燥无定形固体分散体中测定药物-聚合物溶解度:以依非韦伦和Soluplus®为例。
Eur J Pharm Biopharm. 2019 Sep;142:300-306. doi: 10.1016/j.ejpb.2019.06.028. Epub 2019 Jun 24.
7
Solubility parameter-based screening methods for early-stage formulation development of itraconazole amorphous solid dispersions.基于溶解度参数的伊曲康唑无定形固体分散体早期制剂开发筛选方法。
J Pharm Pharmacol. 2016 May;68(5):705-20. doi: 10.1111/jphp.12491. Epub 2016 Feb 10.
8
Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.喷雾干燥无定形固体分散体的水致相分离。
Mol Pharm. 2020 Oct 5;17(10):4004-4017. doi: 10.1021/acs.molpharmaceut.0c00798. Epub 2020 Sep 24.
9
High speed electrospinning for scaled-up production of amorphous solid dispersion of itraconazole.高速静电纺丝用于扩大生产伊曲康唑无定形固体分散体。
Int J Pharm. 2015 Mar 1;480(1-2):137-42. doi: 10.1016/j.ijpharm.2015.01.025. Epub 2015 Jan 14.
10
Influence of solvent composition on the miscibility and physical stability of naproxen/PVP K 25 solid dispersions prepared by cosolvent spray-drying.溶剂组成对溶剂喷雾干燥法制备的萘普生/PVP K25 固体分散体的混溶性和物理稳定性的影响。
Pharm Res. 2012 Jan;29(1):251-70. doi: 10.1007/s11095-011-0539-x. Epub 2011 Jul 20.

引用本文的文献

1
Advancing Drug Delivery Paradigms: Polyvinyl Pyrolidone (PVP)-Based Amorphous Solid Dispersion for Enhanced Physicochemical Properties and Therapeutic Efficacy.推进药物递送模式:基于聚乙烯吡咯烷酮(PVP)的无定形固体分散体以增强理化性质和治疗效果。
Polymers (Basel). 2024 Jan 20;16(2):286. doi: 10.3390/polym16020286.
2
Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?无定形固体分散体诱导的富药相:口服给药中的随意目标还是有意为之?
Pharmaceutics. 2021 Jun 15;13(6):889. doi: 10.3390/pharmaceutics13060889.
3
Predicting process design spaces for spray drying amorphous solid dispersions.

本文引用的文献

1
A fast and reliable empirical approach for estimating solubility of crystalline drugs in polymers for hot melt extrusion formulations.一种用于估计结晶药物在热熔挤出制剂聚合物中溶解度的快速可靠的经验方法。
J Pharm Sci. 2014 Sep;103(9):2847-2858. doi: 10.1002/jps.23941. Epub 2014 Mar 13.
2
Investigation of process temperature and screw speed on properties of a pharmaceutical solid dispersion using corotating and counter-rotating twin-screw extruders.采用同向和异向双螺杆挤出机研究工艺温度和螺杆转速对药物固体分散体性能的影响。
J Pharm Pharmacol. 2014 Feb;66(2):204-17. doi: 10.1111/jphp.12106. Epub 2013 Jul 31.
3
预测喷雾干燥无定形固体分散体的工艺设计空间。
Int J Pharm X. 2021 Feb 25;3:100072. doi: 10.1016/j.ijpx.2021.100072. eCollection 2021 Dec.
4
Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.无定形固体分散体:制备、表征、生物利用度机制、稳定性、监管考虑因素和上市产品的更新。
Int J Pharm. 2020 Aug 30;586:119560. doi: 10.1016/j.ijpharm.2020.119560. Epub 2020 Jun 18.
5
The Investigation of Flory-Huggins Interaction Parameters for Amorphous Solid Dispersion Across the Entire Temperature and Composition Range.非晶态固体分散体在整个温度和组成范围内的弗洛里-哈金斯相互作用参数研究
Pharmaceutics. 2019 Aug 19;11(8):420. doi: 10.3390/pharmaceutics11080420.
6
Prediction of Phase Behavior of Spray-Dried Amorphous Solid Dispersions: Assessment of Thermodynamic Models, Standard Screening Methods and a Novel Atomization Screening Device with Regard to Prediction Accuracy.喷雾干燥无定形固体分散体相行为的预测:关于预测准确性对热力学模型、标准筛选方法及一种新型雾化筛选装置的评估
Pharmaceutics. 2018 Mar 7;10(1):29. doi: 10.3390/pharmaceutics10010029.
Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
利用 Flory-Huggins 相图作为制备无定形固体分散体的预配方工具:热熔挤出法和喷雾干燥法的比较。
J Pharm Pharmacol. 2014 Feb;66(2):256-74. doi: 10.1111/jphp.12141. Epub 2013 Nov 5.
4
The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate.无定形固体分散体的应用:一种克服低溶解度和溶出速率的制剂策略。
Drug Discov Today Technol. 2012 Summer;9(2):e71-e174. doi: 10.1016/j.ddtec.2011.10.002.
5
A new protocol to determine the solubility of drugs into polymer matrixes.一种测定药物在聚合物基质中溶解度的新方案。
Mol Pharm. 2013 Feb 4;10(2):560-6. doi: 10.1021/mp3002254. Epub 2013 Jan 10.
6
Competition of thermodynamic and dynamic factors during formation of multicomponent particles via spray drying.通过喷雾干燥形成多组分颗粒过程中热力学和动力学因素的竞争。
J Pharm Sci. 2013 Feb;102(2):518-29. doi: 10.1002/jps.23378. Epub 2012 Nov 18.
7
Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.利用 Flory-Huggins 相互作用理论构建药物-聚合物热力学相图:确定温度和药物重量分数对固体分散体中相分离的相关性。
Mol Pharm. 2013 Jan 7;10(1):236-48. doi: 10.1021/mp300386v. Epub 2012 Dec 7.
8
Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films.考察萘普生/PVP K25 固体分散体的相行为与氢键相互作用的关系:溶液浇铸和淬火冷却薄膜的评估。
Mol Pharm. 2012 Nov 5;9(11):3301-17. doi: 10.1021/mp3003495. Epub 2012 Oct 15.
9
A method to predict the equilibrium solubility of drugs in solid polymers near room temperature using thermal analysis.利用热分析技术预测室温附近固体聚合物中药物的平衡溶解度的方法。
J Pharm Sci. 2012 Dec;101(12):4549-58. doi: 10.1002/jps.23319. Epub 2012 Sep 16.
10
Assessing the performance of amorphous solid dispersions.评估无定形固体分散体的性能。
J Pharm Sci. 2012 Apr;101(4):1355-77. doi: 10.1002/jps.23031. Epub 2011 Dec 27.